An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Conflict of interest: The authors have declared that no conflict of interest exists.
Figures
Figure 1. No evidence of trained immunity…
Figure 1. No evidence of trained immunity in PBMCs or circulating monocytes after two doses…
Figure 1. No evidence of trained immunity in PBMCs or circulating monocytes after two doses of ChAdOx1-S or BNT162b2 vaccines.
(A) PBMCs collected from participants before vaccination (Pre) and approximately 28 days following (Post) the second dose of the BNT162b2 (n = 33) or ChAdOx1-S (n = 13) vaccines were stimulated in vitro with heat-killed Streptococcus pneumoniae (HKSP), heat-killed Staphylococcus aureus (HKSA), resiquimod (R848), heat-killed Candida albicans (HKCA), or LPS for 20 to 22 hours. Cytokine production was quantified via multiplex immunoassay. (B) Shown is log2 fold-change (median ± 95% CI) in cytokine concentrations (after versus before vaccination). (C) Expression (geometric mean fluorescence intensity [gMFI]) of HLA-DR and CD86 on classical monocytes (before versus after vaccination). (D) Shown is t-distributed stochastic neighbor embedding (t-SNE) analysis of ATAC-Seq data before and after vaccination. (E) Mean chromatin accessibility and (F) representative plots of peaks ± 5 kb of the TSS of selected genes previously shown to have altered accessibility in monocytes following BNT162b2 or BCG vaccination (4, 6). CPM, counts per million. (B, C, and E) Wilcoxon’s log-rank tests (after versus before vaccination). (C) Groups compared via Mann-Whitney U test. **P < 0.01.
Netea MG, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20(6):375–388. doi: 10.1038/s41577-020-0285-6.
-
DOI
-
PMC
-
PubMed
Murphy DM, et al. Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine. J Clin Invest. 2023;133(2):e162581. doi: 10.1172/JCI162581.
-
DOI
-
PMC
-
PubMed
Yamaguchi Y, et al. Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells. JCI Insight. 2022;7(22):e163347. doi: 10.1172/jci.insight.163347.
-
DOI
-
PMC
-
PubMed
Netea MG, Joosten LA. Beyond adaptive immunity: induction of trained immunity by COVID-19 adenoviral vaccines. J Clin Invest. 2023;133(2):e166467. doi: 10.1172/JCI166467.
-
DOI
-
PMC
-
PubMed
Ryan FJ, et al. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines. Cell Rep Med. 2023;4(3):100971. doi: 10.1016/j.xcrm.2023.100971.
-
DOI
-
PMC
-
PubMed